Feasibility Study of IV Recombinant Tissue Plasminogen Activator (rtPA) vs. Primary Endovascular Therapy for Acute Ischemic Stroke

NCT01869478 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Poor recruitment

Conditions

Stroke
Ischemic Stroke

Interventions

DRUG: Intravenous Thrombolysis
DEVICE: Endovascular Arterial Reperfusion

Sponsor

Mayo Clinic